Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable podcast. CIT can also broadcast NIH-only or HHS-only content.

Asymptomatic Primary Hyperparathyroidism, A Perspective for the 21st Century (Day 2)

Loading video...

 
   
Air date: Tuesday, April 9, 2002, 8:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 12 * This only includes stats from October 2011 and forward.
Category: Conferences
Runtime: 07:08:15
Description: A NIH Consensus Development Conference on Asymptomatic Primary Hyperparathyroidism held in 1990 and sponsored by NIDDK explored the causes and effects of this disease, developing a consensus on how to treat it. Together with a research agenda, the consensus statement provided landmarks for basic and clinical approaches to the disease. In the subsequent years many new advances have occurred, including the identification, cloning, and characterization of the PTH/PTHrP receptor and the Calcium Activated Receptor, as well as a series of studies of surgical treatment of Primary Hyperparathyroidism.

Viewers can submit questions or comments to the
Live Event Feedback Form

For more information, visit
http://www.phpt.niddk.nih.gov
Debug: Show Debug
NLM Title: Asymptomatic primary hyperparathyroidism--a perspective for the 21st century [electronic resource] / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Author: National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Publisher:
Abstract: (CIT): A NIH Consensus Development Conference on Asymptomatic Primary Hyperparathyroidism held in 1990 and sponsored by NIDDK explored the causes and effects of this disease, developing a consensus on how to treat it. Together with a research agenda, the consensus statement provided landmarks for basic and clinical approaches to the disease. In the subsequent years many new advances have occurred, including the identification, cloning, and characterization of the PTH/PTHrP receptor and the Calcium Activated Receptor, as well as a series of studies of surgical treatment of Primary Hyperparathyroidism. Viewers can submit questions or comments to the Live Event Feedback Form.
Subjects: Hyperparathyroidism, Primary
Hyperparathyroidism, Primary--therapy
Publication Types: Congresses
Webcasts
Rights: This is a work of the United States Government. No copyright exists on this material. It may be disseminated freely.
Download: To download this event, select one of the available bitrates:
[384k]    How to download a Videocast
NLM Classification: WK 300
NLM ID: 101267450
CIT Live ID: 1562
Permanent link: https://videocast.nih.gov/launch.asp?10064